Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$27,166.21
% of Total Estimate Gain
0.26%

AST MID-CAP GROWTH PORTFOLIO's Edwards Lifesciences Corp Holding Summary

As of 2024-09-30, ADVANCED SERIES TRUST held - shares of Edwards Lifesciences Corp(EW), totaling N/A. This investment constitutes 0% of their stock portfolio, and ADVANCED SERIES TRUST now holds 0% of the outstanding Edwards Lifesciences Corp(EW) stock.

The initial trade took place in 2019Q3. And since then AST MID-CAP GROWTH PORTFOLIO has made 2 purchases of EW, at an average price of $72.64, for a total of 143,063.00 shares. In addition, there have been 7 sales at an average price of $72.83 for 143,063.00 shares. Based on historical transaction data and EW's current price of $78.05, AST MID-CAP GROWTH PORTFOLIO's estimated gain on his EW holdings is $27,166.21, reflecting a 0.26% gain to date.

AST MID-CAP GROWTH PORTFOLIO EW ($78.05) Holding Chart

AST MID-CAP GROWTH PORTFOLIO EW ($78.05) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1